Final Glance: Biotechnology companies

By Associated Press
August 28, 2008 | Comments (0)

Recs

0

Panic 2008... Profit 2009!

Fool -- Now's the time to invest! David and Tom Gardner's new book reveals their strategy for million dollar wealth.

Shares of some top biotechnology companies were mixed at the close of trading:

Amgen rose $.37 or .6 percent, to $64.08.

Biogen Idec rose $.24 or .5 percent, to $51.33.

Celgene fell $.86 or 1.2 percent, to $69.99.

Genentech rose $.55 or .6 percent, to $98.45.

Gilead Sciences fell $.54 or 1.0 percent, to $53.21.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 716932, ~/articles/articlehandler.aspx, 1/8/2009 2:01:07 AM

Sign up for FREE Motley Fool site access!

Already registered? Login Here

It’s FREE! Enter your email address, and we’ll rush you to the article you're looking for right now.

Privacy / Legal Information

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement

.

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Delicious
Print Digg RSS

What Fools Are Saying

Most Recent

Most Recommended

Jan 7 at 4:08 PM

Market Summary

DJIA 8,769.70 -245.40 -2.72%
S&P 500 906.65 -28.05 -3.00%
NASD 1,599.06 -53.32 -3.23%
Sponsored by:

Related Tickers

Amgen, Inc.

CAPS Rating 4/5 Stars

$58.20

-0.14 (-0.24%)

Outperform1775

Underperform156

Rate This Stock

All stories about AMGN